Dexcom (DXCM) Payables (2011 - 2025)

Dexcom's (DXCM) quarterly Payables came in at $1.2 billion in Q3 2025, little changed quarter-over-quarter from $1.2 billion in Q2 2025.

Analysis

Dexcom (DXCM) Payables (2011 - 2025) Analysis & Trends

Dexcom (DXCM) has reported Payables for 6 consecutive years, with $1.2 billion the latest figure, recorded in Q3 2025.

On a quarterly basis, Payables changed N/A year-over-year to $1.2 billion in Q3 2025; TTM through Sep 2025 was $1.2 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $1.2 billion, changed N/A from the prior year.
Payables was $1.2 billion for Q3 2025 at Dexcom, roughly flat from $1.2 billion in the prior quarter.
Over five years, Payables peaked at $1.2 billion in Q3 2025 and troughed at $124.2 million in Q3 2023.
A 4-year average of $908.3 million and a median of $989.1 million in 2023 frame the typical range for Payables.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Abbott Laboratories	184.10 Bn	178.50 Bn	7.27 Bn	5.89 Bn
2	Intuitive Surgical	124.21 Bn	118.99 Bn	1.96 Bn	277.20 Mn
3	Medtronic	118.33 Bn	109.51 Bn	6.34 Bn	2.70 Bn
4	Stryker	104.21 Bn	100.73 Bn	4.50 Bn	2.00 Bn
5	Boston Scientific	66.39 Bn	65.86 Bn	3.85 Bn	1.23 Bn
6	Edwards Lifesciences	49.69 Bn	45.43 Bn	1.35 Bn	210.50 Mn
7	Alcon	33.94 Bn	32.48 Bn	1.68 Bn	968.00 Mn
8	Dexcom	32.18 Bn	30.23 Bn	830.00 Mn	-
9	Steris	21.15 Bn	20.67 Bn	684.20 Mn	587.50 Mn
10	Zimmer Biomet Holdings	18.14 Bn	17.73 Bn	1.54 Bn	352.40 Mn

Historic Data

Download Data